Neuropsychiatric conditions like schizophrenia display a complex neurobiology, which has long been associated with distributed brain dysfunction. However, no investigation has tested whether schizophrenia shows alterations in global brain signal (GS), a signal derived from functional MRI and often discarded as a meaningless baseline in many studies. To evaluate GS alterations associated with schizophrenia, we studied two large chronic patient samples (n = 90, n = 71), comparing them to healthy subjects (n = 220) and patients diagnosed with bipolar disorder (n = 73). We identified and replicated increased cortical power and variance in schizophrenia, an effect predictive of symptoms yet obscured by GS removal. Voxel-wise signal variance was also increased in schizophrenia, independent of GS effects. Both findings were absent in bipolar patients, confirming diagnostic specificity. Biologically informed computational modeling of shared and nonshared signal propagation through the brain suggests that these findings may be explained by altered net strength of overall brain connectivity in schizophrenia.
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resting-state | global signal | psychiatric illness T he brain of humans and other mammalian species is organized into large-scale systems that exhibit coherent functional relationships across space and time (1) . This organizational principle was discovered in the human brain primarily through examination of correlated spontaneous fluctuations in the bloodoxygenation level-dependent (BOLD) signal, which reflects blood flow and is interpreted as a surrogate marker for regional brain metabolic activity (2) (3) (4) . Such resting-state functional connectivity (rs-fcMRI) analyses further revealed the functional architecture of the brain (1, 3) and its alterations in pathological states, wherein disruptions of brain function may be restricted to certain regions, or extend globally because of widespread neurotransmitter abnormalities (5, 6) , possibly affecting widespread global signals (GS) (7) . Schizophrenia (SCZ) has been described as a disorder of distributed brain "dysconnectivity" (8) , emerging from complex biological alterations (9) that may involve extensive disturbances in the NMDA glutamate receptor, altering the balance of excitation and inhibition (10) . The symptoms of SCZ are correspondingly pervasive (11) , leading to a lifetime of disability for most patients (12) at profound economic cost. Understanding the properties of neural disturbances in SCZ constitutes an important research goal, to identify pathophysiological mechanisms and advance biomarker development. Given noted hypotheses for brain-wide disturbances in cortical and subcortical computations (13) , we hypothesized that SCZ might be associated with GS alterations. However, most rs-fcMRI studies discard the GS to better isolate functional networks. Such removal may fundamentally obscure meaningful brain-wide GS alterations in SCZ. It is currently unknown whether prevalent implementation of such methods affects our understanding of BOLD signal abnormalities in SCZ or other clinical conditions that share many risk genes, such as bipolar disorder (BD) (14) .
Spontaneous BOLD signal can exhibit coherence both within discrete brain networks and over the entire brain (7) . In neuroimaging, signal averaged across all voxels is defined as GS. The GS can to a large extent reflect nonneuronal noise (e.g., physiological, movement, scanner-related) (9) , which can induce artifactual high correlations across the brain. Thus, GS is often removed via global signal regression (GSR) to better isolate functional networks. This analytic step presumes that brain-wide GS is not of interest, and its removal can improve the anatomical specificity of some rs-fcMRI findings (15) . However, this common approach remains controversial (16) . Besides noise, GS may reflect neurobiologically important information (7) that is possibly altered in clinical conditions. This reflection is potentially problematic when comparing rs-fcMRI between diagnostic groups that may have different GS profiles. Thus, GS removal may discard critical discriminative information in such instances. This possibility has received little attention in rs-fcMRI studies of severe neuropsychiatric disease, such as SCZ.
We systematically characterized the GS profile across two large and independent SCZ samples (n = 90 and n = 71), where the first "discovery" sample established novel results and the second sample replicated all effects. To establish diagnostic specificity of SCZ findings, we compared them to a cohort of BD patients (n = 73). As a secondary objective, we examined if GSR alters inferences across clinical groups in empirical data. We used both data-driven (17) and seed-based analyses (6, 18) Significance This study identified elevated global brain signal variability in schizophrenia, but not bipolar illness. This variability was related to schizophrenia symptoms. A commonly used analytic procedure in neuroimaging, global signal regression, attenuated clinical effects and altered inferences. Furthermore, local voxel-wise variance was increased in schizophrenia, independent of global signal regression. Finally, neurobiologically grounded computational modeling suggests a putative mechanism, whereby altered overall connection strength in schizophrenia may underlie observed empirical results.
focused on prefrontal and thalamo-cortical circuits, where dysconnectivity in SCZ has been well established. Finally, we used biologically informed computational modeling (19, 20) to explore how alterations in local circuit parameters could impact emergent GS alterations, as observed in SCZ.
Collectively, results illustrate that GS is differentially altered in neuropsychiatric conditions and may contain neurobiologically meaningful information suggesting that GS should be explicitly analyzed in clinical studies. Our modeling simulations reveal that net increases in microcircuit coupling or global connectivity may underlie GS alterations in SCZ.
Results

Power and Variance of the Cortical Gray Matter BOLD Signal Is
Increased in SCZ. We examined the cortical gray matter (CGm) BOLD signal power spectrum in SCZ patients (n = 90), compared with matched healthy comparison subjects (HCS, n = 90) (6) . Using the multitaper periodogram method (21) (SI Appendix), we compared the group-averaged power across frequencies, with and without GSR ( Fig. 1) . To perform GSR, the average signal over all voxels in the brain (GS) was included as a nuisance predictor and regressed out to produce a residual BOLD signal without its GS component (SI Appendix). SCZ patients exhibited higher CGm average power [F(1, 178) = 7.42, P < 0.01] and variance [F(1, 178) = 7.24, P < 0.01] than HCS (i.e., Group main effect). As expected, removal of GS (and its frequency contributions) through GSR reduced the power amplitudes in all frequency domains across groups [F(1, 178) = 248.31, P < 0.0001]) and attenuated CGm variance [F(1, 178) = 245.6, P < 0.0001] (i.e., main effect of Preprocessing). SCZ patients showed greater reductions in CGm power (averaged over all subjects and frequency domains) [F(1, 178) = 5.37, P < 0.025] and variance [F(1, 178) = 5.25, P < 0.025] because of GSR (i.e., Group × Preprocessing interaction) ( Fig. 1 A-C) . Put simply, the GSR effect was greater in SCZ than HCS. To verify "discovery" findings, we repeated analyses in an independent sample of 71 SCZ patients and 74 HCS, fully replicating increased CGm power/variance in SCZ and the effect of GSR ( Fig. 1 D-F) . Reported effects held when examining all gray matter tissue (as opposed to cortex only) (SI Appendix, Fig. S1 ) and were not present in ventricles (SI Appendix, Fig. S2 ). Interestingly, SCZ effects were more preferential for higher-order networks, but were not evident in visual/motor networks (SI Appendix, Fig.  S12 ), suggesting that, despite robust GS effects, elevated variability may be particularly apparent in associative networks. We also controlled for known confounds (movement, smoking, medication dose and medication type), which did not explain reported findings (Discussion and SI Appendix, Figs. S3 and S14).
Next, to investigate the diagnostic specificity of SCZ effects, we examined an independent sample of 73 BD patients and 56 matched HCS. Strikingly, there was no increase in CGm power in BD relative to HCS; the trend was toward reduced CGm power in BD, the opposite of what we observed in SCZ [F(1, 127) = 3.06, P = 0.083, n.s.]. GSR did not significantly alter the between-group difference for BD vs. HCS [no Group × Preprocessing interaction: F(1, 127) = 2.9, P = 0.092, n.s.] ( Fig. 1 G-I) . In addition, SCZ effects remained relative to BD patients after explicit movement matching (SI Appendix, Fig. S12 ) and controlling for medication type (SI Appendix, Fig. S14 ).
Finally, to establish the clinical relevance of SCZ effects, we examined the relationship of CGm power and variance with SCZ symptom severity ( Fig. 2 and SI Appendix, Fig. S4 ). In the discovery sample (n = 90), we identified a significant relationship between positive SCZ symptoms and the magnitude of average CGm power before GSR (r = 0.18, P < 0.03; ρ = 0.2, P < 0.015). Effects replicated in the independent SCZ cohort [r = 0.18, P < 0.05; ρ = 0.18, P < 0.05; joint P (independent replications) < 0.002] ( Fig. 2 ) and were particularly prominent for Disorganization symptoms across samples [ρ(discovery) = 0.26, P < 0.01; ρ(replication) = 0.25, P < 0.025; joint P (independent replications) < 0.001]. Interestingly, symptom effects were attenuated and no longer significant following GSR, suggesting removal of clinically meaningful information.
Elevated Voxel-Wise Variance in SCZ Remains Following GSR. We demonstrated that SCZ is associated with elevated power/variance relative to HCS both across cortex and all gray matter ( Fig. 1 and SI Appendix, Fig. S1 ). It remains unknown if SCZ is associated with altered "local" variance structure of each voxel's time series. To test this hypothesis, we compared whole-brain voxel-wise variance maps across diagnostic groups (Fig. 3 ). If specific regions are driving the increases in CGm power/variance, this analysis should reveal focal (or region-specific) clusters of between-group difference.
We identified increased voxel-wise variance in SCZ relative to HCS, across discovery and replication samples ( Fig. 3A) . At first, the increase appeared diffuse, suggesting widespread increases in voxel-wise signal variance in SCZ. We tested for preferential Table S3 for demographics) did not reveal GSR effects observed in SCZ samples [F(1, 127) = 2.89, P = 0.092, n.s.] and no evidence for increase in CGm power or variance. All effects remained when examining all gray matter voxels (SI Appendix, Fig. S1 ). Error bars mark ± 1 SEM. ***P < 0.001 level of significance. n.s., not significant. S4 ). Notably, all effects were no longer significant after GSR, suggesting GS carries clinically meaningful information. The shaded area marks the 95% confidence interval around the best-fit line.
colocalization of voxel-wise effects, again showing robust effects within the fronto-parietal control network (SI Appendix, Fig.  S13 ). The spatial pattern remained virtually unchanged after GSR, indicating that increased BOLD variance in SCZ has both local and global components that are at least somewhat independent of one another. Of note, local variance effects were somewhat apparent across tissues (SI Appendix, Fig. S5 ). These patterns of increased voxel-wise variance were again specific to SCZ ( Fig. 3B ): BD patients showed no such increase before or after GSR. Importantly, these results were also fully movement scrubbed, reducing the possibility that the increased voxel-wise variance in SCZ was exclusively driven by motion (22) (however, see Discussion). These findings illustrate the need to carefully decompose signal variance into global and local components, which may be differentially affected in neuropsychiatric conditions (see modeling for possible neurobiological implications).
Data-Driven Prefrontal Connectivity Results Are Altered Because of
Higher GS Variance in SCZ. Present effects have important implications for the widespread use of GSR in rs-fcMRI clinical studies, which remains controversial (16, 23) . If groups differ in GS properties, GSR may affect between-group differences in complex ways (23) . Informed by the neurobiology of SCZ, we tested this possibility in two ways: focusing on prefrontal cortex (PFC) (17) and thalamo-cortical networks (6, 18, 24) .
It is well established that SCZ involves profound alterations in PFC networks (25) . Previous rs-fcMRI studies have identified specific functional connectivity reductions in the lateral PFC in chronic SCZ patients (17) . Using a data-driven global brain connectivity (GBC) analysis restricted to the PFC (rGBC), we tested whether GSR affects this pattern of between-group differences (SI Appendix). Here we collapsed the two SCZ samples to achieve maximal statistical power (n = 161). With GSR, we replicated prior findings (17) showing reduced lateral PFC rGBC in SCZ ( Fig. 4 ). Without GSR, however, between-group difference patterns were qualitatively altered ( Fig.4 A and B) : we found evidence for increased rGBC in chronic SCZ, and no evidence for reductions. This discrepancy between analyses could have occurred for two reasons. First, because of large GS variance in SCZ, GSR could have resulted in a "uniform" transformation of variance structure, whereby the mean between-group difference is reduced but the topography of voxel-wise between-group differences remains the same (Fig. 4E ). Despite the unchanged topography of the between-group difference, statistical thresholding may lead to qualitatively distinct between-group inferences after GSR in this scenario (Fig. 4E ). Alternatively, GSR could alter the topography of rGBC differentially across groups, resulting in qualitatively different results before and after GSR (i.e., a nonuniform transformation) ( Fig. 4F ). It is vital to distinguish between these two alternatives in patient data because of complex implications the second possibility may have on clinical restingstate studies (16) .
To this end, we computed a quantitative index of statistical similarity (eta 2 ) for the PFC rGBC between-group difference maps before and after GSR using validated metrics (26) . If GSR fundamentally altered the topography of rGBC, we would expect low similarity. However, we found high similarity in the structure of rGBC computed with and without GSR (SI Appendix, Fig. S8 ), suggesting a relatively uniform transform of the between-group effect after GSR ( Fig. 4E ).
Further analysis of the thalamo-cortical connectivity also suggests preserved structure of between-group inferences following GSR (SI Appendix, Figs. S6 and S7), replicating prior studies (18) . However, GSR shifted the distributions of thalamocortical connectivity for all groups into the negative range (SI Appendix, Figs. S6 and S7), impacting some conclusions drawn from the data (Discussion and SI Appendix).
Collectively, these results do not definitively answer whether to use GSR in clinical connectivity studies. Instead, effects suggest that GS needs to be characterized explicitly in clinical groups to determine its contributions in connectivity analyses (SI Appendix, Figs. S6 and S7). Based on the outcome of such analyses, researchers can reach a more informed decision if GSR is advisable for specific analyses (Discussion).
Understanding Global Signal and Local Variance Alterations via
Computational Modeling. Presented results reveal two key observations with respect to variance: (i) increased whole-brain voxelwise variance in SCZ, and (ii) increased GS variance in SCZ. The second observation suggests that increased CGm (and Gm) power and variance ( Fig. 1 and SI Appendix, Fig. S1 ) in SCZ reflects increased variability in the GS component. This finding is supported by the attenuation of SCZ effects after GSR. To explore potential neurobiological mechanisms underlying such increases, we used a validated, parsimonious, biophysically based computational model of resting-state fluctuations in multiple parcellated brain regions (19) . This model generates simulated BOLD signals for each of its nodes (n = 66) ( Fig. 5A ). Nodes are simulated by mean-field dynamics (20) , coupled through structured long-range projections derived from diffusion-weighted imaging in humans (27) . Two key model parameters are the strength of local, recurrent self-coupling (w) within nodes, and the strength of long-range, "global" coupling (G) between nodes ( Fig. 5A ). Of note, G and w are effective parameters that describe the net contribution of excitatory and inhibitory coupling at the circuit level (20) (see SI Appendix for details). The pattern of functional connectivity in the model best matches human patterns when the values of w and G set the model in a regime near the edge of instability (19) . However, GS and local variance properties derived from the model had not been examined previously, nor related to clinical observations. Furthermore, effects of GSR have not been tested in this model. Therefore, we computed the variance of the simulated local BOLD signals of nodes (local node-wise variability) ( Fig. 5 B and  C) , and the variance of the "global signal" computed as the spatial average of BOLD signals from all 66 nodes (global model Fig. 3 . Voxel-wise variance differs in SCZ independently of GS effects. Removing GS via GSR may alter within-voxel variance for SCZ. Given similar effects, we pooled SCZ samples to maximize power (n = 161). (A and B) Voxel-wise between-group differences; yellow-orange voxels indicate greater variability for SCZ relative to HCS (whole-brain multiple comparison protected; see SI Appendix), also evident after GSR. These data are movement-scrubbed reducing the likelihood that effects were movement-driven. (C and D) Effects were absent in BD relative to matched HCS, suggesting that local voxel-wise variance is preferentially increased in SCZ irrespective of GSR. Of note, SCZ effects were colocalized with higher-order control networks (SI Appendix, Fig. S13 ). variability) ( Fig. 5 D and E). Critically, this in silico global signal differs from empirical GS because it contains only neural contributions (and by definition no physiological artifact). We examined model dynamics as a function of w and G (see parameter space in Fig. 5F ). The local variance of each node increased as a function of increasing w and G ( Fig. 5 B and C). This finding suggests that the empirically observed increase in voxel-wise variance in SCZ might arise from increased neural coupling at the local and long-range scales. The variance of simulated GS increased as a function of increasing w and G ( Fig. 5 D and E). These effects were robust to particular patterns of large-scale anatomical connectivity (SI Appendix, Fig. S9 ). Finally, effects of GSR resulted in attenuated model-based variance, a pattern that was quite similar to clinical effects ( Fig. 5 B-E, dashed lines; see SI Appendix for GSR implementation). The GS variance was completely attenuated given that in silico GSR effectively removes the model-derived signal mean across all time points.
These modeling findings illustrate that GS and local variance alterations can possibly have neural bases (as opposed to driven exclusively by physiological or movement-induced artifacts). The abnormal variance in SCZ could arise from changes in w and G, perhaps leading to a cortical network that operates closer to the edge of instability than in HCS ( Fig. 5F ).
Discussion
Power and Variability of BOLD Signals in SCZ. Local cortical computations, and in turn large-scale neural connectivity, are profoundly altered in SCZ (13) . One outcome of such dysconnectivity could be an alteration in the distributed gray matter BOLD signal, reflected in increased variance/power. We identified results consistent with this hypothesis before GSR in a large SCZ sample (n = 90), and replicated findings in an independent sample (n = 71). This effect was absent in BD patients, supporting diagnostic specificity of SCZ effects. After GSR, the BOLD signal power/ variance for cortex and gray matter was significantly reduced across SCZ samples, consistent with GSR removing a large variance from the BOLD signal (28) . However, removing a GS component that contributes abnormally large BOLD signal variance in SCZ could potentially discard clinically important information arising from the neurobiology of the disease, as suggested by symptom analyses. Such increases in GS variability may reflect abnormalities in underlying neuronal activity in SCZ. This hypothesis is supported by primate studies showing that resting-state fluctuations in local field potential at single cortical sites are associated with distributed signals that correlate positively with GS (7) . Furthermore, maximal GSR effects colocalized in higher-order associative networks, namely the fronto-parietal control and default-mode networks (SI Appendix, Fig. S12 ), suggesting that abnormal BOLD signal variance increases may be preferential for associative cortices that are typically implicated in SCZ (29, 30) .
Although it is difficult to causally prove a neurobiological source of increased GS variance here (given the inherent correlational nature of BOLD effects), certain analyses add confidence for such an interpretation. First, the effect was not related to smoking or medication. Second, the effect survived in movement-scrubbed and movement-matched data, inconsistent with head-motion being the dominant factor. Third, albeit modest in magnitude, increased CGm power was significantly related to SCZ symptoms (particularly before GSR), an effect that Fig. 4 . rGBC results qualitatively change when removing a large GS component. We tested if removing a larger GS from one of the groups, as is typically done in connectivity studies, alters between-group inferences. We computed rGBC focused on PFC, as done previously (17) , before (A and B) and after GSR (C and D). Red-yellow foci mark increased PFC rGBC in SCZ, whereas blue foci mark reductions in SCZ relative to HCS. Bars graphs highlight effects with standard betweengroup effect size estimates. Error bars mark ± 1 SEM. (E) GSR could uniformly/rigidly transform between-group difference maps. Because of larger GS variability in SCZ (purple arrow) the pattern of between-group differences is shifted, rendering increased connectivity in SCZ as the dominant profile (red signal above the 95% confidence interval indicated by green planes). If GSR shifts the distribution uniformly, then the increased connectivity is now within the 95% confidence interval, but focal reduction becomes apparent with preserved topography. (F) Alternatively, GSR could differentially impact the spatial pattern (i.e., nonuniformly transforming data, illustrated by a qualitatively different pattern before and after GSR). We conducted focused analyses to arbitrate between these possibilities, suggesting that the effect is predominantly uniform (SI Appendix, Fig. S8 ). Note: topographies in E and F represent a conceptual illustration, and do not reflect specific patient data. ***P < .001.
Computational modeling simulation of BOLD signal variance illustrates a biologically grounded hypothetical mechanism for increased global and local variance. (A) We used a biophysically based computational model of resting-state BOLD signals to explore parameters that could reflect empirical observations in SCZ. The two key parameters are the strength of local, recurrent self-coupling (w) within nodes (solid lines), and the strength of long-range, global coupling (G) between 66 nodes in total (dashed lines), adapted from prior work (19) (B and C) Simulations indicate increased variance of local BOLD signals originating from each node, in response to increased w or G. (D and E) The GS, computed as the spatial average across all nodes, also showed increased variance by elevating w or G. Shading represents the SD at each value of w or G computed across four realizations with different starting noise, illustrating model stability. Dotted lines indicate effects after in silico GSR. (F) Two-dimensional parameter space, capturing the positive relationship between w/G and variance of the BOLD signal at the local node level (squares, far right color bar) and the GS level (circles in each square, the adjacent color bar). The blue area marks regimes where the model baseline is associated with unrealistically elevated firing rates of simulated neurons. Model simulations illustrate how alterations in biophysically based parameters (rather than physiological noise) can increase GS and local variance observed empirically in SCZ. Of note in B-E, when w is modulated, G = 1.25. Conversely, when G is modulated, w = 0.531. For permutations of anatomical connectivity matrixes, mean trends and complete GSR effects, see SI Appendix, Figs. S9-S11.
replicated across samples, thus unlikely to have occurred by chance alone. Importantly, CGm/Gm power and variance increases were diagnostically specific, as the pattern was not identified in BD patients, even when controlling for movement and medication type (SI Appendix, Figs. S3 and S14). Of note, cumulative medication impact is notoriously difficult to fully capture quantitatively in crosssectional studies of chronic patients; therefore, longitudinal study designs are needed to confirm present effects (although, see SI Appendix, Fig. S14 ). Finally, given evidence for network specificity of present SCZ effects, it is highly unlikely that metabolic, cardiovascular, movement or breathing-rate effects impacted these results (i.e., effects were not as evident in sensory-motor and visual networks, although present in associative networks) (SI Appendix, Fig.  S12 ). Nevertheless vigilance levels (31) need to be ruled out (32) .
Importantly, findings are indicative of a coherent signal contribution as opposed to random noise (supported by power analysis). Increased power could indicate disrupted neuronal communication, reflecting a shift in the baseline amplitude or durations of cortex-wide signals. A global increase in durations of signal oscillations across frequencies, revealed in increased average power, could reflect globally delayed inhibition of local microcircuit signals in the setting of altered global connectivity.
In addition to elevated GS variance, we examined local voxelwise variance in SCZ. We observed, irrespective of GSR, that SCZ is associated with increased local voxel-wise variance. The effect was again diagnostically specific and not found in BD, highlighting three points: (i) The unchanged whole-brain voxel-wise variance pattern illustrates that the spatial distribution of this variability is largely unaffected by GSR. (ii) Even when high-variance GS is removed, there remains greater voxel-wise variability in SCZ (despite movement-scrubbing). (iii) Interestingly, both the GS and voxel-wise effects colocalized preferentially around associative cortices (SI Appendix, Figs. S12 and S13), suggesting that these disturbances may reflect signal alterations in specific higher-order control networks, in line with recent connectivity findings (30) .
Although these analyses were performed on movement-scrubbed data, it may be possible that micromovements still remain (33) , which studies using faster acquisition (34) could address. Relatedly, a recent rigorous movement-related investigation (35) suggests that motion artifacts can spatially propagate as complex waveforms in the BOLD signal across multiple frames.
Effect of Large GS Variance on Between-Group Comparisons:
Methodological Implications. A key objective of this study was empirical, namely to establish evidence for greater GS variance in SCZ. However, this finding has methodological implications for many future clinical connectivity studies, as GSR has been hypothesized to impact patterns of between-group differences in such studies (16, 23) . Here it is important to examine which measures may be sensitive to GSR in between-group clinical comparisons because of greater GS variance in SCZ. We tested this using two broad approaches centered on system-level abnormalities implicated in SCZ, namely thalamo-cortical (24) and PFC dysconnectivity (17, 36) .
Across all thalamo-cortical analyses we found that, irrespective of GSR, SCZ was associated with the same relative direction of differences compared with HCS, as reported previously (18) . However, an interesting motif emerged: before GSR the direction of the effect suggested that SCZ and HCS display positive thalamo-cortical connectivity, wherein the magnitude of SCZ connections exceed those of HCS. In contrast, after GSR both groups were associated with negative thalamo-cortical connectivity, wherein the magnitude of SCZ was lesser than HCS. Here we also considered using correlations versus covariance to quantify thalamo-cortical signals, given arguments suggesting that correlation coefficients may not be always ideal (37) (SI Appendix, Figs. S6 and S7). These results highlight that clinical studies dealing with different magnitudes of BOLD signal variance across groups may consider decomposing correlations, to allow a nuanced inference regarding the alterations in functional connectivity.
We also tested if GSR impacts data-driven patterns of between-group differences. We used a well-validated data-driven metric to capture global PFC connectivity (17) . In contrast to thalamo-cortical results, GSR affected between-group rGBC inferences. Using GSR we replicated prior findings indicating reductions in rGBC centered on lateral PFC (17) . However, without GSR the pattern of between-group differences was consistent with PFC hyperconnectivity in chronic SCZ, in contrast to prevalent hypotheses that postulate PFC hypofunction (25) . This discrepancy raises an important point: significant differences in rGBC results pre-and post-GSR show that GSR can affect some between-group inferences.
The discrepancy, however, could have occurred because of two very different scenarios, which have distinct implications regarding GSR effects on between-group comparisons. One possibility, suggested by certain mathematical modeling simulations (16) , is a nonuniform data transformation when removing a larger GS from one group. Furthermore, if the magnitude of the global BOLD variability is larger for one group, in combination with this nonuniform effect, then the resulting between-group effect will be different in magnitude and spatial pattern (Fig. 4F ). The alternative is that GSR generally induces a rigid or uniform data transformation ( Fig. 4E ). Put differently, the magnitude of the total Gm variability may be greater for one group, but its spatial effect on voxel-wise connectivity is the same across groups. Present findings support the latter possibility (SI Appendix, Fig.  S8 ), suggesting that GS removal does not fundamentally alter the spatial topography of between-group differences.
Collectively, PFC and thalamic analyses indicate that GSR does not necessarily always change between-group inferences. In cases where GSR qualitatively altered between-group effects, the discrepancy reflected a uniform data shift ( Fig. 4) . Nevertheless, removing a GS component from one group could affect the conclusions drawn about some between-group difference (given the observed sign reversal) (28) . Therefore, the preferred strategy for future clinical connectivity studies may be twofold: (i) studies should first carefully examine GS magnitude and power spectra in each group to determine if they are indeed different; and (ii) studies should test for the direction of clinical inferences before and after GSR to allow a nuanced interpretation regarding the observed connectivity alterations (16) . Such a stepwise approach is critical to circumvent the debate whether to use GSR or not and instead use rigorous data inspection to support appropriate study-specific analytic decisions (see SI Appendix for further discussion).
Neurobiological Mechanisms of GS Alterations in SCZ. Lastly, we studied a biophysically based computational model of rs-fcMRI to enhance our understanding of BOLD effects in SCZ (19) . The simulations showed increased GS variance after elevating local node self-coupling (w) and global coupling (G) between nodes. The modeling results also revealed a collective increase in local variance for all simulated nodes as a result of increasing w or G parameters. These simulations serve as an initial proof-of-principle, showing that changes in GS and local variance can have neural bases, rather than purely reflecting nonneural variables (as the model explicitly excludes such signal sources). Empirical measures of local and GS variability can potentially be used to probe specific neurobiological changes in cortical microcircuitry and long-range interactions. Applying this model to healthy humans, Deco et al. proposed that resting-state cortex operates near the edge of instability, based on matching the empirically observed functional connectivity (19) . Using a similar architecture, we show that GS and local variance increase near the edge of the instability by elevating w and G. It is possible that SCZ patients operate even closer to this edge than in HCS, which could potentially expose a vulnerability to perturbations. Furthermore, in silico GSR attenuated this increase in variance, as observed clinically (dashed lines in Figs. 1 and 5). Future studies can extend these proof-of-principle modeling findings to interpret BOLD signal changes following SCZ illness progression (13) , which would also better control for some limitations of present cross-section data. In turn, modeling can provide insights for neuroimaging studies using pharmacological interventions, such as the NMDA receptor antagonist ketamine, which may alter local and long-range synaptic interactions in vivo (38) .
Of note, SCZ is associated with both glutamatergic (excitatory) and GABAergic (inhibitory) deficits in local microcircuits (39) as well as striatal dopamine abnormalities (40) . Within the model, G and w reflect the net contributions of excitatory and inhibitory interactions in cortical circuits. Other computational modeling and neurophysiological evidence using behaving monkeys (41) suggest that a reduction of local recurrent excitation could explain cognitive deficits associated with SCZ. Present results can be reconciled with these observations by considering excitation/inhibition balance (E/I balance) (42) . Our modeling results suggest that in the resting state, SCZ is associated with an increased E/I balance of either local or long-range, which is in line with the hypothesis of prominent inhibitory deficits in chronic SCZ (43) . It remains to be determined how current modeling simulations relate to complex network measures (36) and to task-based cognitive deficits observed in SCZ (44) .
Conclusion
This study addresses vital gaps in understanding GS in neuropsychiatric illness. (i) Results show that the GS is profoundly altered in SCZ but not BD. (ii) GSR can affect between-group analyses, altering conclusions in complex ways. (iii) Results show that future clinical neuroimaging studies need to systematically assess GS and consider its impact upon system-level connectivity inferences. Finally, this study highlights the possible neurobiological importance of global/local BOLD signal variance alterations in SCZ, which may relate to synaptic coupling disruptions that could be amenable to pharmacological intervention.
Experimental Procedures
Participants. For comprehensive procedures regarding subject selection, inclusion/exclusion criteria, group matching, medication, and symptom analyses, see SI Appendix.
Neuroimaging. For a full description of acquisition, processing and all neuroimaging analyses see SI Appendix.
Computational Modeling. We used a validated computational model of resting-state functional connectivity (19) , extending a local circuit model (20) to incorporate biologically plausible mechanisms for BOLD signal fluctuations. Complete modeling details are presented in the SI Appendix.
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Participant Inclusion Criteria and Characteristics. Here we studied three independent clinical samples: i) 90 chronic SCZ patients and 90 demographically matched HCS ( . As in our prior studies, these measures were normed and converted to IQ equivalents for each subject. If more than one premorbid achievement measure was available per subject the scaled scores were averaged per standard practice (4) . An important consideration in the present study is whether identified effects in any way relate to cognitive impairment in SCZ. Related to this question, the 'IQ' measures are based on measures that assess premorbid academic achievement levels and do not capture the more complex higher-order cognitive deficits (5) . While this question is beyond the scope of our investigation, future studies should systematically examine if cognitive impairment relates to presently identified effects, In the present study we did not exclude patients with a lifetime co-morbid Axis I anxiety disorders and/or history of substance abuse in the schizophrenia sample to ensure an inclusive and representative sample of patients (6) . However, all discovery SCZ sample participants were required to be fully remitted >6 months prior to the study. Healthy comparison subjects (HCS) (N=90) were recruited through media advertisements and flyers posted in the Medical Center area. Inclusion criteria for HCS were: i) no current or lifetime Axis I psychiatric disorder as assessed by SCID-NP; ii) no history of medical or neurological conditions; and iii) no history of psychotic disorders in first-degree relatives (reported by detailed family history). The bipolar disorder (BD) sample participants (N=73) were recruited at the same site as the SCZ discovery sample. The same general exclusion/inclusion criteria were applied, described previously in more detail (7) (8) (9) .
As noted, the SCZ 'replication' sample was provided to the neuroimaging community by COBRE researchers. Critically, this large and independent SCZ sample has been extensively characterized, demographically matched and quality-assured across a number of prior reports (http://fcon_1000.projects.nitrc.org/indi/retro/cobre.html). Replication sample SCZ patients were excluded if they had: i) history of neurological disorder, ii) history of mental retardation, ii) history of severe head trauma with more than 5 minutes loss of consciousness; iv) history of substance abuse or dependence within the last 12 months. Diagnostic decisions were reached using the SCID interview for the DSM-IV. Collectively, these criteria and demographic are highly comparable across the two SCZ samples.
To allow full inspection of these clinical samples we provide complete demographics details in Tables S1-3. Across all samples we accomplished matching on a number of relevant demographic variables, ensuring comparable between-group demographics. The discovery sample groups did not significantly differ on any of the variables (see Table S1 ), apart from educational attainment and premorbid intellectual functioning (IQ) (see aforementioned comments). IQ was lower for SCZ patients, and likely reflects the shortened educational achievement for patients due to illness onset (10) . Also, education differences are impacted by the illness course and thus were not considered as a covariate as they likely reflect illness trajectory. Notably, alcohol/drug use, age, gender, smoking status and medication did not alter reported effects for the discovery sample (see Fig. S3 for comprehensive confound analyses). 75/90 schizophrenia patients were receiving antipsychotic treatment. SCZ patients for the COBRE replication sample were also receiving stable doses of antipsychotic medication with no medication changes for at least 1 month. All medication were converted to chlorpromazine (CPZ) equivalents (11) and verified by trained raters (AA & AS). We used CPZ levels as a covariate for our discovery analyses and we verified that the CPZ values did not correlate with the CGm power and variance main effects (see Fig. S3 ). Critically, the two SCZ samples that were recruited across different sites received somewhat different levels of medication doses. Yet, the key effects replicated across both SCZ patient samples. Collectively, these results are inconsistent with medication being a major confound in our analyses.
Schizophrenia Symptoms. Schizophrenia symptom severity, across both samples, was determined using the Positive and Negative Syndrome Scale (PANSS), a widely-used symptom instrument, which captures positive, negative and general psychopathology symptom dimensions (12) (Table S1 ). BD patients were in remission at the time of the scan (7), therefore no symptom analyses were attempted.
Neuroimaging Data Acquisition. The SCZ discovery, the BD sample and the their respective HCS participated in neuroimaging data collection at the Olin Neuropsychiatry Research Center using a Siemens-Allegra 3T scanner with identical acquisition parameters (7) . Images sensitive to blood oxygenation leveldependent (BOLD) signal were acquired with axial slices parallel to the anterior-posterior commissure (AC-PC) using a T2*-weighted gradient-echo, echo-planar sequence (TR/TE=1500/27ms, flip angle=60°, field of view=24x24 cm, acquisition matrix=64x64, voxel size=3.43x3.43x4mm) covering the whole brain. The acquisition lasted 5.25 minutes and produced 210 volumetric images per subject (29 slices/volume, inter-slice gap=1mm). Subjects were instructed to lay awake in the scanner and keep their eyes open. Subjects were monitored on a video camera to ensure that they stayed awake and were removed from the analyses if they fell asleep during the scan or if their head movement exceeded 1mm along any axis. Structural images were acquired using a T1-weighted, 3D magnetization-prepared rapid gradient-echo (MPRAGE) sequence (TR/TE/TI=2200/4.13/766ms, flip angle=13°, voxel size [isotropic]=.8mm, image size=240x320x208 voxels), with axial slices parallel to the AC-PC line. SCZ patients comprising the replication sample (N=71) and their respective HCS (N=74) underwent data collection at Center for Biomedical Research Excellence using a Siemens Tim-Trio 3T scanner. Full acquisition details for the SCZ replication sample and HCS is detailed previously (13) (14) (15) . Briefly, BOLD signal was collected with 32 axial slices parallel to the AC-PC using a T2*weighted gradient-echo, echo-planar sequence (TR/TE=2000/29ms, flip angle=75°, acquisition matrix=64x64, voxel size=3x3x4mm). The acquisition lasted 5 minutes and produced 150 volumetric images per subject. Structural images were acquired using a 6 minute T1-weighted, 3D MPRAGE sequence (TR/TE/TI=2530/ [1.64, 3.5, 5.36, 7.22, 9. 08]/900, flip angle=7°, voxel size [isotropic]=1mm, image size=256x256x176 voxels), with axial slices parallel to the AC-PC line. All the described parameters were provided via the publically-distributed website (http://fcon_1000..projects.nitrc.org/indi/retro/cobre.html).
Neuroimaging Preprocessing & Analysis. Preprocessing followed prior validated approaches that were applied to clinical populations (7, 9) . Critically, we performed identical preprocessing procedures across all subjects collected across scanners, which were then registered to the same common standard space and interpolated to the same resolution. We first performed the following preprocessing steps for all BOLD images, as done in our prior studies (7, 9) : i) slice-time correction, ii) first 5 images removed from each run, iii) rigid body motion correction, iv) 12-parameter affine transform of the structural image to the Talairach coordinate system, and v) co-registration of volumes to the structural image with 3x3x3mm re-sampling, ensuring all BOLD images across both scanners were interpolated to the same resolution.
In addition, all BOLD images had to pass stringent quality assurance criteria to ensure that all functional data were of comparable and high quality: i) signal-to-noise ratios (SNR)>100, computed by obtaining the mean signal and standard deviation (sd) for a given slice across the BOLD run, while excluding all non-brain voxels across all frames (7) . The final samples had high SNR values (see Tables S1-3); ii) movement scrubbing as recommended by Power et al. (16, 17) . As accomplished previously (18) , all image frames with possible movement-induced artifactual fluctuations in intensity were identified via two criteria: First, frames in which sum of the displacement across all 6 rigid body movement correction parameters exceeded 0.5mm (assuming 50mm cortical sphere radius) were identified; Second, root mean square (RMS) of differences in intensity between the current and preceding frame was computed across all voxels divided by mean intensity and normalized to time series median. Frames in which normalized RMS exceeded the value of 3 were identified. The frames flagged by either criterion were marked for exclusion (logical or), as well as the one preceding and two frames following the flagged frame. Movement scrubbing was performed for all reported analyses across all subjects except for the power frequency analyses. The scrubbing step was omitted in this case, because removing arbitrary frames would have corrupted the time-dependent frequency information of the signal. Nevertheless, all effects remained robust with complementary analyses techniques (i.e. variance analyses) following stringent movement scrubbing and after explicitly controlling for movement (see Fig. S3 ).
Collectively, these quality assurances add confidence that typical neuroimaging confounds (i.e. SNR or movement) are not driving present effect.
Lastly, to remove spurious signal in resting-state data we completed additional preprocessing steps, as is standard practice (19) : all BOLD time-series underwent high (>0.009 Hz) and low (<0.08 Hz) pass temporal filtering, removal of nuisance signal extracted from anatomically-defined ventricles, white matter, and the remaining brain voxels (i.e. global signal) (all identified via individual-specific FreeSurfer segmentations (20)), as well as 6 rigid-body motion correction parameters, and their first derivatives using previously validated inhouse Matlab tools (21) .
Where appropriate, type I error correction was implemented via threshold-free cluster enhancement (TFCE) non-parametric techniques implemented in FSL's Randomise tool(22) (e.g. for the GBC analyses, see below for details). Results were visualized using Caret 5.5 (http://brainvis.wustl.edu/wiki/index.php/Caret) and NeuroLens software (http://www.neurolens.org).
Global Signal Regression (GSR)
. GSR was performed using standard procedures(23) by calculating mean raw BOLD signal averaged over all voxels for each time point, explicitly excluding ventricles and white matter signal (which are defined as separate nuisance regressors). The GS and its first derivative (with respect to time) were used as nuisance predictor terms within a multiple linear regression model along with other nuisance predictor terms (ventricular signal, white matter signal, movement parameters, and the first derivatives of each of these, as noted above).
Power Analysis.
To quantify the impact of GSR on the frequency content of CGm and Gm BOLD signal, we evaluated frequency amplitudes using the multi-taper periodogram method, available as part of the Nitime Time-Series Analysis library (http://nipy.org/nitime/) (24) . The first 5 volumes were discarded to allow for stable BOLD signal levels. We quantified the CGm power in each group and preprocessing condition by computing each individual's average CGm frequency amplitude across all frequencies recorded from the periodogram of the CGm (or Gm) signal. The resulting average CGm power calculated for each individual was entered as a dependent measure into all 2 nd level ANOVA analyses.
CGm/Gm Signal and Thalamic Isolation. Across a number of analyses we quantified the alterations in CGm/Gm signal in SCZ versus BD as a function of GSR. Moreover, we computed the relationship between the CGm and anatomically-defined thalamic nuclei for each individual (see below). To extract appropriate Gm/CGm or thalamic signal for each individual we used individual-specific FreeSurfer segmentations (20) , which were visually inspected for quality by a trained rater (AA) ( Table S4 lists all FreeSurfer codes used across analyses). We extracted the BOLD signal from regions labeled as belonging to CGm/Gm for each individual, which was then used in all subsequent analyses. Similarly, we identified thalamic BOLD signal by extracting average time-series across all voxels in each subject's bilateral thalamus, as done previously (1) .
Whole-brain Voxel-wise Variance Analysis.
To test the hypothesis that voxel-wise whole-brain variance may be altered in SCZ, we computed the variability of each voxel's time-series with and without GSR. This analysis is distinct from the variability of the CGm in that it computes the variance of each voxel, as opposed to the, spatial average across all Gm/CGm voxels. We computed the variability of each voxel's time series after all noted preprocessing steps, including movement scrubbing. We did so for all SCZ patients, combining the discovery and replication samples (given a highly similar pattern of results) (N=161). We repeated the voxelwise analyses for BD patients to establish diagnostic specificity. Following the variance calculation, we computed a whole-brain voxel-wise between-group t-test for SCZ patients relative to HCS, treating each voxel's variance as the dependent variable. That is, we obtained a voxel-wise variance map for each subject, where each voxel's value represents its variability over time.
PFC Connectivity Analysis. The data-driven global brain connectivity (GBC) approach (9, 25) was applied using in-house Matlab tools, here restricted to the PFC (referred to hereafter as restricted global brain connectivity -rGBC). We focused on the PFC given numerous prior studies implicating PFC dysfunction in SCZ (26) , and to remain maximally powered given the smaller search space of PFC voxels. Furthermore, our prior reports identified PFC rGBC alterations in chronic SCZ, which served as a basis for comparison. Importantly, the PFC rGBC analysis is fully data-driven, adding a complementary technique to the thalamic seed-driven analyses. Specifically, rGBC provides a sensitive measure by computing correlational strength of each voxel with all other voxels being considered. As previously described (7, 9, 25) , GBC is designed to estimate the connectivity between each individual voxel and every other voxel in the brain or a restricted search space. Thus, rGBC is optimized to estimate connectivity at every voxel with every other voxel in a specific search space (in this case PFC).
As done previously (7, 9) , we conducted rGBC analysis restricted to voxels only within subject-specific anatomically defined PFC gray matter masks defined via Freesurfer software(20) (see Table S4 for a list of all relevant FreeSurfer codes). All PFC Freesurfer segmentations were also visually inspected for quality by a trained rater (AA). Before rGBC analysis, BOLD signal within the subject-specific cortical mask was spatially smoothed with a 6mm full-width-at-half-maximum (FWHM) Gaussian kernel and dilated by two voxels (6mm) to account for individual differences in anatomy. Finally, for each PFC voxel, we computed a correlation with every other PFC voxel, transformed the correlations to Fisher z-values, and finally computed their mean. This calculation yielded an rGBC map for each subject where each voxel value represents the mean connectivity of that voxel with the rest of PFC (see Fig. 4 ).
Quantification of Between-Group Difference Map Similarity and Overlap.
The data-driven PFC rGBC analyses ( Fig. 5) suggest that GSR may affect the pattern of between-group differences in complex ways that result in distinct between-group effects before and after this processing step is applied. Because of the larger magnitude of the GS variability in SCZ, this could lead to two distinct possibilities, as noted in the main text: i) GSR could have introduced a 'uniform' shift in the data that is just larger in magnitude for the SCZ group; ii) GSR could have introduced a 'non-uniform' shift such that the effect is differentially distributed across voxels for one group versus the other, a possibility articulated by mathematical simulations (27) . We designed two analyses to arbitrate between these possibilities: 1) Testing for Similarity of Between-Group rGBC Maps Before and After GSR: If the spatial configuration of the rGBC is non-uniformly affected by GSR then the between-group maps should be qualitatively distinct (i.e. they should not be similar before and after GSR). Conversely, if the pattern is largely similar but just uniformly shifted by a rigid transform (see Fig. 4E ), then the statistical similarity of the maps should be high (without any statistical threshold employed). To distinguish between these hypotheses and assess the similarity of betweengroup difference maps pre/post GSR via a single value, we made use of the eta 2 index that quantifies the pattern of similarity between two signals, or in this case functional images. Briefly eta 2 is designed to vary from 0 for no similarity to 1 for perfect signal similarity; for further detail see (28) . That is, the employed method was explicitly designed to capture similarity (eta 2 ) between a pair of functional connectivity maps (28) . To accomplish this calculation we converted the Fz between-group difference maps to one-dimensional vectors for each PFC voxel. Next, we computed eta 2 between vectors before and after GSR. This calculation captured the similarity across the two between-group maps before and after GSR without any statistical threshold employed. In addition to eta 2 we also used standard r-values. However, there are important benefits of using eta 2 : whereas r reflects only the dissimilarities in the pattern of connectivity, eta 2 also captures possible differences in the connectivity strength for voxels with similar connectivity patterns. Therefore, the resulting eta 2 captures the overall 'similarity' between two connectivity maps -in this case the maps showing betweengroup differences before and after GSR:
As described in detail by Cohen and colleagues (28) , here ai and bi correspond to connectivity at position i (in this case a given voxel in the PFC) for maps a and b respectively (in this case the between-group difference for patients vs. control before (map A) and after (map B) GSR). mi corresponds to the mean value of the two images at position i, (ai+bi)/2. M-bar represents the grand mean value across the mean image (designated by m). By computing, eta 2 and r-values we are able to quantitatively assess the degree of similarity between resulting maps pre and post GSR (see Fig. S8A-B) .
2) Testing for Percentage of Overlapping Voxels of Between-Group rGBC Maps Before and After GSR: The eta 2 and r-value calculations above provide a single index of statistical similarity before and after GSR. However, to further assess if the similarity is dominated by a certain 'range' of values in the statistical map, we quantified the percent of overlapping voxels for the two between-group difference maps at a given peak level (i.e. with different levels of thresholding applied). To accomplish this we first rank-ordered all the voxels across the between-group difference PFC rGBC map before and after GSR. Next, we selected voxels that fell only in a given range but that were either at the top or bottom of the range (here the top voxels reflect regions that are higher in SCZ than CON, whereas bottom ranked voxels would reflect regions where CON are higher than SCZ). We specifically used a sliding window where we selected the top/bottom 1%, 5%, 10% and 20% of the voxels. Put simply, if the maps show a large degree of similarity then the spatial overlap for each of the selected ranges should be significantly higher than what would be expected by chance (and should not be dominated by only a single range). After computing the percentage of voxels that overlap across the two between-group difference maps, we tested for significance of overlap using the binomial proportion test (as done in prior work (1)) (see Fig. S8C ).
Thalamo-Cortical Connectivity Analyses as a Function of Global Signal Removal (GSR).
To quantify whether GSR altered thalamo-cortical relationships in SCZ versus BD, we computed two separate but complementary analyses: i) We quantified the relationship between CGm (i.e. the entire cortical gray matter for each subject) and the thalamus. This analysis was explicitly designed to be non-specific (i.e. considering the entire CGm BOLD signal) to provide proof-of-principle examination of the ways in which large-scale thalamo-cortical relationships can be altered by GSR differentially across different neuropsychiatric conditions. We computed thalamocortical connectivity using the Pearson's correlation coefficient (r), which was then de-composed into variance and covariance components. The aim was to examine whether shared versus non-shared sources of variance in cortical/thalamic signals are differentially altered as a function of GSR. Put simply, GSR may uniquely impact the variability of different regional BOLD signals in SCZ. In such a case the correlation coefficient may not be a precise measure given that it combines both shared and non-shared variability (29) .
ii) Several studies (30, 31) , including our group(1), identified profound alterations in thalamo-cortical connectivity in SCZ. These neuroimaging investigations observed a pattern whereby SCZ was associated with thalamic over-connectivity with sensory-motor regions, but thalamic under-connectivity with prefrontalcerebellar regions (1, 31 ). Here we rigorously tested whether GSR would affect between-group differences within areas identified in our prior study. Although we examined the effects of GSR broadly in the analyses described above (juxtaposing the total CGm results before and after GSR), here we explicitly quantified its effects within the identified subset of areas known to show thalamic-cortical dysconnectivity in SCZ. Briefly, we computed the whole-brain seed-based thalamus correlation map using the N=90 SCZ discovery sample, a result originally reported and characterized in our prior study(1) (see Fig. S6-7) . Next, we extracted the average time-series across all voxels in each subject's bilateral anatomically-defined thalamus (again through subject-specific Freesurfer-based segmentation (20, 32) ). This thalamic signal was then correlated with each gray matter voxel and the computed Pearson correlation values were transformed to Fisher Z values (Fz) using a Fisher r-to-Z transform. This yielded a map for each subject, where each voxel's value represents connectivity with the thalamus. Between-group differences, Fz maps were entered into an independent samples t-test, results of which were reported in detail in our prior work (1) . We used these identified areas showing over/under thalamic connectivity in SCZ to test the effects of GSR on the pattern of between-group differences for the discovery SCZ sample (N=90), which served to identify these effects originally (1) . We repeated all analyses for the SCZ replication sample (N=71) and BD sample (N=73), both fully statistically independent of the discovery effect ( Fig. S6-7) . The key objective was to examine if GSR would alter the pattern of between-group inferences when focusing on specific thalamo-cortical systems known to exhibit dysconnectivity in SCZ.
Computational Modeling Framework.
As noted in the main text, here we employed a validated computational model of resting-state functional connectivity (33) , extending a local circuit model (34) , to incorporate biologically plausible mechanisms for BOLD signal fluctuations. The network is composed of 66 nodes and is a dynamic mean-field model (34) , coupled through a large-scale anatomical connectivity matrix, which was derived from diffusion tractography in humans as reported in Hagmann et al. (35) . We extracted the anatomical connectivity matrix from Fig. 1 of Deco & Jirsa (36) . Specifically, the digital image provided an RGB value for each connection that we quantitatively matched to a calibrated color bar, allowing us to extract the quantitative strengths of the connections which we used as in prior modeling studies (36) .
Of note, the strengths of global connections allow for an undetermined scale factor, which accounts for differences in the range of G and w values between this study and that of Deco et al. (33) . BOLD signals were simulated via the Balloon-Windkessel model, as done previously . We parametrically varied strengths of local self-coupling (w) within nodes and global coupling (G) between nodes. Default values were set to w=0.531, G=1.25, and sigma=0.0004. All reported effects did not depend qualitatively on the specific default values, as shown in Fig. 5F . All other parameter values were set to those of Deco and colleagues . To realistically capture the percentage of BOLD signal variance represented by the GS variance, we introduced a common input to all nodes, mimicking low baseline level correlations seen empirically in gray matter. Specifically, a shared noise term of amplitude 0.0005 was added to the signal of all nodes.
In the original model implementation, Deco and colleagues (2013) utilized different default w/G/sigma values and did not incorporate a common shared signal component. When using the original approach, we found the results to be somewhat unrealistic given the known large contribution of GS in empirical data (see Fig. 1 ). For instance, in our empirical data, we found that ~90% of the variance of the healthy control BOLD signal was accounted for by the GS component, which constitutes the upper bound of GS, reflecting both neuronal and physiological signal present in vivo. Therefore, we implemented a common noise input into our model architecture. This way we were able to simulate a neuronal GS that accounts for 77% of the total simulated BOLD signal variance at default values given above (see Figure S15 for a parameter sweep showing percentage of GS at different values of w/G/sigma). We opted for this value to account for the fact that empirical GS certainly contained a physiological non-neuronal component. In turn, these adjustments produced a very robust effect of GSR in silico (see Figure 5 , dotted lines), as seen empirically (see Figure 1 , dotted lines). Put simply, by including a 'common' noise signal (amplitude=0.0005) we observed a much more realistic effect of GSR in the model. Implementing GSR in the Model. In the model architecture, we implemented a GSR component in the following way: i) A GS was computed across as the spatial average over all n=66 nodes:
where t is time and BOLD i (t) is the signal for node i as a function of time.
ii) To mimic the effects of GSR, as computed empirically, we conducted GSR for each node in the model (as would be done per voxel in vivo):
where again t is time, BOLD i (t) is the signal for node i as a function of time, and BOLD i GSR (t) is the signal after GSR for that node.
SI RESULTS
Influence of Confounding Variables on Cortical Power & Variance in SCZ.
The increase in CGm power and variance is robust across our two independent SCZ samples, but it could still be related to statistical or physiological confounds. We examined several possible confounds suggested by previous literature: i) smoking status, which could affect BOLD fluctuations via oxygen availability in the lungs (37) ; ii) psychotropic medication levels, which affect measured functional connectivity (38) ; and iii) head motion (16) (Fig. S3) .
First, we explicitly compared smoker (N=50) vs. non-smoker (N=46) SCZ patients (collapsing across both replication and discovery samples with available smoking status information, N=96 total). CGm power [t(94)=.51, p=.61, NS] and variance [t(94)=.54, p=.59, NS] did not differ as a function of smoking status (Fig.  S3A-B) . Consistent with the findings not being driven by confounds of smoking, CGm power [t(138)=3.23, p<.0016] and variance [t(138)=3.22, p<.0016] were still significantly higher for non-smoking SCZ patients vs. non-smoking HCS prior to GSR (Fig. S3A-B) .
To examine the effect of medication, we converted all medication levels to chlorpromazine (CPZ) equivalents, a standard measure of overall level of psychotropic medication (11) . For the discovery SCZ sample the CPZ equivalents did not significantly correlate with either CGm power (r=-.03, NS) or variance (r=-.02, NS) ( Fig. S3C-D) . The same result was observed in the replication sample for power (r=.1, NS) and variance (r=.1, NS), suggesting medication dosage cannot explain the GS effects observed in SCZ.
Lastly, we sought to rigorously establish that movement did not drive our core effects via two follow-up analyses. First, we examined the CGm power/variance effects across N=100 HCS and N=100 SCZ (evenly selected across the samples) explicitly statistically matched for the number of frames eliminated during movement scrubbing (19% frames for SCZ and 17.22% frames for HCS, p=.22, NS). We also movementscrubbed these data for the variance analyses (Fig. S3F) . The CGm power [(t(198) =2.12, p<.036] and variance [(t(198) =2.14, p<.035] remained elevated in SCZ relative to HCS ( Fig. S3E-F, left panels) . We performed the same analysis in N=73 SCZ and N=73 BD patients statistically matched for the number of frames scrubbed (13.22% frames for SCZ and 11.24% frames for BD, p=.13, NS). This cross-diagnostic analysis further confirmed that increased CGm power [t(144)=2.03, p<.045] and variance [t(144)=2.1, p<.04] are specific to SCZ, even when explicitly comparing movement-matched clinical groups ( Fig. S3E-F , left panels). In combination, these analyses are not supportive of a relationship between CGm power/variance effects in SCZ and smoking, medication or movement.
Between-Group Differences in Variance and Covariance Structure of Thalamo-Cortical Signals Are Reduced and Change Sign As a Function of GSR.
We demonstrate that the average CGm signal power is significantly increased in SCZ and that GSR reduces average CGm power/variance differentially across clinical groups (Fig. 1) . As noted, this discovery has methodological implications for all future connectivity studies. To illustrate this issue, we present data-driven connectivity analyses (Fig. 4) suggesting that removal of large GS variance from one of the groups can affect the final pattern of between-group results. Another possible methodological consequence is that such large GS variance could in turn alter system-level covariance relationships differentially before and after GSR in SCZ (27) .
Building on recent evidence suggesting that thalamo-cortical connectivity is altered in SCZ (31, 39) , we first investigated the consequences of differential GSR effects upon large-scale thalamo-cortical relationships. Specifically, we examined the correlation (a commonly used measure of functional connectivity) between thalamic and CGm signals with and without GSR. However, use of correlations can at times be problematic in between-group clinical comparison because this measure combines the shared and non-shared sources of variability (29) . That is, the correlation coefficient normalizes the covariance between signals, by using the variance of each of the signals (Fig. S6, bottom panel) . We hypothesized that this can result in conflicting between-group inferences if the variance structure of each signal is different between groups and/or differentially altered across groups as a function of GSR. Therefore, to fully parse effects, we decomposed the correlation into covariance and variance components ( Fig. S6A-D) .
As noted, CGm signal variance was significantly higher in SCZ relative to HCS [F(1,178)=7.24, p<0.01]. Also, thalamic and CGm variances were significantly altered across groups as a function of GSR (thalamic variance alteration [F(1,178)=12.02, p<0.001], CGm variance alteration [F(1,178)=5.246, p<0.03]). We also observed a significant group difference in CGm-thalamic covariance [F(1,178)=21.52, p<0.0001] (Fig. S6A,  top) , which GSR altered differentially for each group (i.e. group x preprocessing interaction [F(1,178)=12.52, p<0.001]). Next, by computing the correlation coefficient (Fig. S6D) , we found in the discovery sample that patients' average correlations between CGm and thalamic signal also significantly differed from HCS (i.e. group main effect [F(1,178)=23.59, p=0.0001]) (Fig. S6D, top) . However, the GSR effect on between-group differences was no longer significant (i.e. group x preprocessing interaction [F(1,178)=0.32, p=0.57, ns]). That is, the average thalamo-cortical correlation group differences were similar before and after GSR (Fig. 6D, top) . This was in contrast to the measures of average CGm-thalamic covariance, where SCZ patients' measures became more similar to those of HCS after GSR. All findings were fully replicated in the independent SCZ sample (n=71) ( Fig. S6A-D, middle row) , which underwent identical movement scrubbing (see Experimental Procedures). This might initially suggest that correlations can perhaps be effective in dealing with GSR vs. non-GSR differences when conducting between-group comparisons because between-group correlation differences do not seem to be attenuated by GSR. However, correlations could be potentially problematic in some cases for the same reason that GSR is problematic: both obscure a variance component from betweengroup comparisons. The observation that GSR has no effect on reducing between-group correlation differences likely arises from correlations having already 'normalized' some of the variance that would otherwise have been removed by GSR.
A parallel examination of the BD sample showed significant between-group differences in thalamic variance (Fig. S6C, bottom row) [F(1,127) =8.99, p<0.01] and CGm-thalamic covariance (Fig. S6A , bottom row) [F(1,127)=7.37, p<0.01], but no significant between-group differences in CGm variance (as reported in Fig. 1) . In contrast to SCZ, GSR did not alter between-group differences in the BD sample for any of the measures, again demonstrating diagnostic specificity of the SCZ GSR effect (all p-values >0.08). Interestingly, the thalamo-cortical covariance and correlation relationships for the BD patients show striking similarities to those found for SCZ patients when contrasted with HCS. Yet, BD exhibited lower CGm and thalamic variance than SCZ prior to GSR. In other words, the correlation structure may be insufficient to distinguish SCZ from BD; more specificity was gained from additionally examining variance. Collectively, these observations further suggest that correlations may sometimes not be ideal when the variance structure drastically differs across clinical groups. Alternatively, depending on the goal of the study, correlations could be used because they provide results untarnished by differences in variability. Considering these pros and cons will likely depend on the type of research question and selecting the best statistical metric for a given inference.
Notably, GSR did not significantly alter the between-group differences of CGm-thalamic correlation for any of the patient samples ( Fig. S6D top, middle, bottom rows ). Yet, GSR did significantly alter the magnitude of between-group differences in CGm-thalamic covariance for both SCZ samples but not for the BD sample. In addition, across all analyses, GSR resulted in a 'shift' of positive thalamo-cortical covariance (or correlations) into the negative range for all three groups, altering interpretations for all findings, as predicted by prior simulation studies (40) . That is, in each case SCZ and BD showed a more positive value relative to HCS, but after GSR all values changed sign and the gap between SCZ and HCS relationships reduced -a notable difference from the inferred connectivity strength before GSR. Collectively, these effects show how GSR can in some cases impact the variance and covariance structure of large-scale thalamo-cortical systems for different between-group comparisons, leading to possibly conflicting inferences depending on the preprocessing method.
Covariance/Correlation Structure of A Priori Defined Thalamo-Cortical Networks Do Not Change Sign
After GSR. As noted above, based on the discovery of larger GS power/variance, an important objective was to explore how GSR could differentially impact inferences across different clinical analyses. We first focused on the relationship between thalamus and CGm, which is known to be disrupted in SCZ. As discussed above, these covariance analyses were significantly affected by GSR. However, GSR could potentially produce different effects when focusing on thalamo-cortical relationships within a priori selected regions(31) of cortex, rather to the entire cortex. To test this more specific case we examined previously identified regions that show thalamo-cortical dysconnectivity in SCZ, independently replicated by several groups (1, 30, 31) . Specifically, prior studies identified two types of thalamo-cortical alterations in SCZ: i) regions showing reductions in thalamic coupling (i.e. under-connectivity), and ii) regions that show increases in thalamic coupling (i.e. overconnectivity)(1). Here we tested, using these a priori defined areas (see SI Experimental Procedures above), whether GSR altered between-group inferences. This analysis accomplishes two important additional objectives: i) based on present effects it is vital to examine their methodological implications; namely, whether GSR alters established findings in the literature; ii) this analysis provides another replication of prior effects(1), via an independent SCZ sample (N=71). In turn, such independent verification of thalamo-cortical effects provides, irrespective of GSR, additional confidence for future studies focusing on this finding as a viable SCZ biomarker.
Notably, these analyses are distinct from results above (which averaged the entire CGm signal). That is, here we examine whether between-group differences in subsets of thalamo-cortical connections remain unaltered by GSR. As predicted, we observed significant GSR effects (40) . However, correlation and covariance measures for SCZ patients retained the same sign after GSR (Fig. S7) instead of inverting as observed for the total CGm analysis (Fig. S6) . HCS patterns generally retained the same sign after GSR (Fig.  S6) . Thus, the overall polarity of thalamo-cortical findings (irrespective of GSR) remained unchanged across samples, showing that certain types of between-group analyses remain more robust to GSR. The discrepancy between these system-specific effects and analyses above that focused on the entire cortex could occur if GSR homogeneously decreases variance across cortex in SCZ (described in Fig. S3 ). This would effectively shift the whole-brain pattern of covariance relationships in a way that attenuates differences between patients and HCS (since GSR drastically reduces a major difference between SCZ and HCS: the CGm variance). Conversely, when a priori regions are defined for functional connectivity (as done here using prior discoveries(1)), then the between-group effect may remain robust and retain the same sign irrespective of GSR. This consideration is potentially important for studies focusing on a priori selected regions versus those using data-driven analyses (see Fig. 4 and S8 for data-driven effects focused on PFC).
Lastly, here we also found that using the correlation coefficient did not always fully capture the alteration in thalamo-cortical relationships before and after GSR (as was observed for covariance, see Fig.  S6 ). This difference of sensitivity to GSR is caused by the large variance component in the denominator of the correlation equation for SCZ prior to GSR -the resulting correlation "divides out" the variance, and is therefore less sensitive to further decrements in variance resulting from GSR, whereas covariance is more vulnerable to variance-reducing processes such as GSR. Collectivity, these thalamo-cortical effects illustrate a complex impact of GSR on system-level inferences in SCZ (see Discussion for a set of recommendations for future clinical connectivity studies).
Computational Modeling -Calculating Mean GS Values.
In addition to variance calculations, we also examined mean levels of node-wise signal amplitude and GS amplitude in the model. We found that the mean of simulated GS also increased as a function of G and w (Fig. S10) . This pattern was expected because the mean value of each simulated local signal also increased as a function of G and w, and GS is the average of local signals. This increase in mean signal values reflects an increase in local recurrent excitation, which will in turn drive up the signal at each local node. Additionally, increased global coupling across nodes will result in an elevated signal propagating throughout all the nodes, thereby increasing mean local node signal levels.
Computational Modeling -Examining Effects of GSR. Once implemented, GSR resulted in attenuated local variance in the model, a pattern that was quite similar to the empirical effects (see Fig. 1 ). However, the GS variance was virtually completely effaced given that implementing GSR in the model subtracts the entire mean of the model-derived signal across all time points. What remains is mathematically zero (see Fig. S11 ).
SI DISCUSSION
Implications for the controversy regarding the role of global signal regression in resting state connectivity analyses. The principal findings of the current study do not offer an unequivocal suggestion to perform GSR or not. However, several attempted rigorous analyses (see Fig. 4 in the main text, as well as Fig.  S6, S7 & S8) demonstrate that this is complex issue, depending on the particular analysis. Therefore, the clearest possible recommendation that one can make to the neuroimaging community based on these results is to carefully examine and analyze the GS across all clinical connectivity analyses. As noted in the main text, these effects indicate that GS needs to be characterized explicitly in clinical groups to determine its potential contributions in focused connectivity analyses (see Fig. S6-7) . Only once such analyses have been completed in a given dataset, researchers can reach a more informed decision if GSR is advisable. Furthermore, as shown here, future studies should test for the direction of clinical inferences before and after GSR to allow a nuanced interpretation regarding the observed connectivity alterations. Such a step-wise approach is critical to improve connectivity-derived neuroimaging markers in neuropsychiatric research, circumventing the debate whether to use GSR or not; instead employing rigorous data inspection to support appropriate study-specific analytic decisions. (11) . * denotes a significant T statistic for the between-group t-test. (11) . * denotes a significant T statistic for the between-group t-test. Table S3 . Bipolar Disorder Sample Demographics. M, Mean; SD, Standard Deviation; age, education levels, and parental education are expressed in years. *denotes a significant T statistic for the between-group t-test. For complete clinical details and clinical measures used for the bipolar sample please see prior studies (7) .
SI TABLES & FIGURES
Fig. S1. Power and Variance of All Gray Matter Signal in Schizophrenia and Bipolar Disorder. (A) Left:
Power of the gray matter signal (Gm) in 90 schizophrenia (SCZ) patients (red) relative to 90 healthy control subjects (HCS) (see Table S1 for demographic details) extending cortex-specific effects (Fig. 1). (B) The bar graph shows the mean power across the entire frequency range for both groups before and after GSR, indicating an increase in SCZ [F(1,178)= 7.64, p<0.01]. As with the cortex analyses, the effect is significantly attenuated after the GSR processing step is used [F(1,178)= 5.9, p<0.02]. (C) Variance of the Gm replicated the power effects showing increases in SCZ [F(1,178)= 7.42, p<0.01] and also verified that GSR attenuates the finding [F(1,178)= 5.75, p<0.02]. (D-F) As with the cortical analyses, here we fully replicated the pattern of results using an independent sample collected at a different site and diagnosed independently (see Table S2 for demographic details), again confirming the increase in Gm power Table S3 for BD demographic details) did not reveal the effect of GSR observed in the SCZ samples [F(1,127)=3.05, p=0.08, n.s.] and there was no evidence for increase in Gm power or variance for the BD patient sample. These results across all gray matter voxels follow the effects reported for the cortical gray matter analyses (see Fig. 1 ). Error bars mark +/-1 standard error of the mean. , patients with schizophrenia who were not smokers (SCZ-NS, N=50) and patients with schizophrenia who were identified as smokers (SCZ-S, N=46) across both discovery and replication datasets. The power and the variance of the CGm were significantly increased for both SCZ-NS and SCZ-S relative to HSC prior to GSR (p<.01 for both measures), whereas there was no difference between SCZ-NS and SCZ-S [t(94)=.52, p=.61, NS], suggesting smoking status does not explain the increased CGm variance and power effects in SCZ. Of note, smoking related to lifetime smoking status (i.e. whether a patient was ever a smoker). Therefore, cumulative effects of smoking could not drive effects for non-smokers as they have never smoked.
(C-D) The magnitude of CGm power and variance before and after GSR did not significantly relate to medication levels across subjects (all p-values >.4), calculated via CPZ equivalent conversion for the discovery sample (11) and did not differ between medicated versus unmedicated patients for the discovery sample (all pvalues >.2). The same pattern was present for the replication sample (all p-values >. 25) . (E-F) We identified N=100 HSC and N=100 SCZ evenly across the two samples that were explicitly matched on the amount of frames flagged for movement (19% frames for SCZ and 17.22% frames for HCS, p=.22, NS). The power and the variance of the CGm are significantly increased for SCZ relative to HSC prior to GSR (p<.04 for both measures) even when explicitly matched for number of flagged frames. Next, we identified N=73 SCZ and N=73 BD that were explicitly matched on the amount of frames flagged for movement (13.22% frames for SCZ and 11.24% frames for BD, p=.13, NS). Again, CGm power and variance were significantly increased for SCZ relative to BD prior to GSR (p<.045 for both measures), further establishing the diagnostic specificity of present effects. This analysis in particular guarantees that effects persist when, by definition, they cannot be confounded by movement. That is, head motion cannot confound effects in an analysis where the number of flagged frames is explicitly matched across groups, guaranteeing that the amount of movement is not different across samples. Error bars mark +/-1 standard error of the mean. We show voxel-wise map of between-group differences whereby each yellow-orange voxel indicates greater local variability for SCZ relative to matched healthy control subjects (HCS) (at Z>3, p<.0013 uncorrected). This pattern is shown for (A) gray matter, (B) white matter and (C) ventricles. Notably, the increase in voxel-wise variance was clearly evident in gray matter, but was also somewhat apparent across other tissue types. One possibility, despite the careful implementation of movement scrubbing (16) , (41) is that these patterns (especially in white matter and ventricles) are in part influenced by sub-TR motion (i.e. micro-movements) that remain challenging to fully rule out in the present study, but may propagate as complex waveforms throughout the BOLD signal (16) . More careful de-noising and movement correction strategies will be needed to comprehensively remove any possibility of movement-related artifacts contributing to these voxel-wise effects.
Meds -CPZ Equivalent
In addition, using accelerated BOLD acquisition methods(42) could further attenuate the possible impact of motion. The correlation between CGm and thalamic signal is shown. For illustrative purpose, figures are presented along with the equation on the bottom to highlight the importance of carefully de-composing the final correlation into variance and co-variance components, given that inference can change. Collectively, these analyses show that removal of GS reverses the sign of the between-group effects, but does not drastically alter the final inference (i.e. SCZ > HCS in thalamo-cortical coupling). However, SCZ is better distinguished from BD in variance comparisons than in correlation or covariance comparisons. Error bars mark +/-1 standard error of the mean.
Between-group differences in
Fig. S7. Examining the Effect of GSR in Schizophrenia and Bipolar Disorder on Specific Thalamo-Cortical Networks.
Above we characterized thalamo-cortical signals across the entire cortical mantle (Fig.  S5) ; however, we also tested whether GSR alters specific thalamo-cortical network inferences given the large GS power/variance in schizophrenia (SCZ). For this purpose we conducted a focused re-analysis of our previously published effects(1), where we identified both reductions and increases in thalamo-cortical connectivity in SCZ (panel A adapted with permission from (1)). (A) Regions showing reduced (blue, top panel) and increased (red, bottom panel) thalamic connectivity in individuals with SCZ relative to HCS, which we identified in our prior work (1) . Because these robust effects were replicated by three independent research groups(1, 31, 43) they provide a basis for investigating the effect of GSR in SCZ, motivated by our primary findings. Here we show results, specifically within the identified areas showing increased (left, panels B,D,F) versus reduced (right, panels C,E,D) thalamic connectivity. Each effect is presented with and without GSR. We conducted this analysis for the original SCZ discovery sample (B-C), for the SCZ replication sample (D-E) and the bipolar disorder (BD) sample (F-G). Collectively, the results illustrate that, irrespective of GSR, the pattern of between-group inferences is not altered and overall findings do not change sign after GSR. Error bars mark +/-1 standard error of the mean. The data-driven rGBC results ( Fig. 5) suggest that GSR may induce a non-uniform transformation of between-group differences by 'shifting' some connectivity values differentially for schizophrenia (SCZ) vs. healthy comparison subjects (HCS). Here we tested whether results are consistent with this possibility, or whether they are more indicative of a uniform transformation (see Fig. 5E -F for a schematic illustration). (A) The between-group PFC rGBC difference map is shown for only 20% of the top ranked vs. 20% of the bottom ranked voxels. Dark blue and orange voxels highlight the results with GSR performed, whereas the light blue and yellow voxels highlight the results without GSR performed. As indicated by this qualitative map, the overlap was generally quite high for both positive and negative connection ranges (white arrows highlight two example areas with high overlap). This overlap map is not supportive of a non-uniform transformation. (B) To verify this observation statistically we quantified the statistical similarity for the PFC rGBC between-group difference maps before and after GSR using r and eta 2 metrics (we used both measures to provide convergent validity via complementary measures, see SI Experimental Procedures for details) (28) . Both metrics showed highly significant levels of similarity (both >.8). This robust level of similarity pre and post GSR is inconsistent with the GSR introducing a strictly non-uniform transform (as the similarity would be around chance or approaching 0). (C) We also examined the resulting voxel overlap without a threshold applied before and after GSR. We did so across four different peak levels (1%, 5%, 10% and 20% top and bottom ranked voxels showing between-group differences). Again, if GSR fundamentally altered the structure of between-group differences then we would expect the overlap to be quite low across these peak levels. In contrast, we observed that, irrespective of the peak level used, the maps before and after GSR showed a highly significant level of overlap (binomial test for proportions, all p<.0001, chance marked with horizontal lines). Collectivity, these analyses are inconsistent with the hypothesis that GSR induces a non-uniform transform. 
Fig. S9. Permutations of the Structural Connectivity Matrix Does Not Alter the Net Effect Across
Parameters. We tested whether the specific configuration of the structural connectivity matrix (35) affected the net pattern of the modeling results. That is, it is important to establish that the predominant effect is an increase in global and local variance as function of G, w and sigma (noise parameter in the model), as opposed to a decrease. To this end, we re-permuted the connectivity matrix randomly (n=100) and re-ran all modeling simulation. (A-C) We computed the average node variance (top panels in red) and the global signal (GS) variance across all nodes (bottom panels in green) as a function of G, w and sigma parameters. Next, we computed the slope of the effect for each of the permutations (either positive slope or negative slope). By chance alone we would expect 50% of the modeling simulations to show a positive versus negative slope. However, for each parameter, irrespective of the structural connectivity matrix configuration, we observed a positive slope (binomial test for proportions, p<.001 for each test). This suggests that the modeling results are generic properties of the model and are not necessarily highly sensitive to the particular configuration of structural connectivity patterns. In the main text we presented the effects of in silico GSR, juxtaposed next to the original model simulations (see Fig. 5 ). Here we present the full pattern of results following model-based GSR via the parameter-scape visualization. (A) The model scheme is shown as in the main text. (B) Two-dimensional parameter space following GSR. This simulation captures the decreased variance following GSR at the local node-wise level (squares, far right color bar), Implementing GSR reduces the GS to zero; this is not surprising as GSR effectively subtracts the GS component (circles in each square, the adjacent color bar). Modeling Results After GSR Figure S12 . Characterizing Specificity of the Increased Cortical Variance Effects in SCZ -Focus on Large Scale Networks. We discovered significantly elevated GS variability in SCZ (Fig. 1) . However, it remains possible that this GS variability is preferentially localized to certain networks, especially given existing theoretical models in SCZ suggesting more profound neural disruptions in higher-order associative networks (44) . To test this hypothesis, we formally quantified the pattern of elevated variability within specific a priori defined large-scale networks, which were characterized independently via resting-state in healthy adults (obtained with permission from Power and colleagues (45) (G-I) Although numerically higher for SCZ, variance effects within the visual network and (J-L) the sensory-motor network were not significant for any Group main effects or interactions. Also between-group t-tests prior to GSR were not significant (both pvalues >0.23). Note: Across the bar plot panels we highlight the pairwise effects (only significant for SCZ relative to HCS in panel B & E) as well as all the Group x Processing (only significant for SCZ vs. HCS in the higher-order associative networks, panels B & E). These preferential network effects further rule out movement concerns; it is highly unlikely that two separate patient samples collectivity move their fronto-parietal and default networks more than their visual-motor networks. Figure S13 . Characterizing Specificity of the Voxel-wise Effects in SCZ -Focus on Large Scale Networks. We discovered significantly elevated voxel-wise variability across distributed cortical and subcortical regions in SCZ (Fig. 3) . The pattern appeared widespread and rather diffuse, but it raises the question of whether these effects co-localized preferentially within specific large-scale networks. To this end, we formally quantified the pattern of elevated voxel-wise variability with specific a priori defined networks, as done for the GS effects in Fig. S12. (A) To accomplish this, we used the sensory-motor network map defined independently via resting-state by Power and colleagues (2011) (obtained with permission from (45)). (B) 15% of all voxels belonging to sensory-motor networks defined a priori (black borders) overlapped with the elevated voxel-wise variance map (chance overlap = 24.6%). (C) In contrast, 42% of all voxels belonging to frontoparietal networks defined a priori (black borders) overlapped with the elevated voxel-wise variance map (chance overlap = 11% because there are less total fronto-parietal voxels). To confirm this statistically we ran a binomial test for difference in proportions: 42% versus 15% of spatial overlap between the two sets of networks significantly exceeded the proportion difference expected by chance alone (Z=35.51, p<0.000001, binomial test for difference between proportions). Importantly, the fronto-parietal overlap (panel C) was significantly higher than expected by chance alone (Z=65.94, p<0.000001, binomial test for proportions), whereas the sensorymotor overlap was actually significantly lower than would have been expected by chance (as by chance alone we would expect approximately ~24.6% overlap (given the number of voxels in the sensory-motor networks defined here relative to all possible voxels belonging to the Power networks). Again, these preferential network effects further rule out movement concerns; it is highly unlikely that two separate patient samples collectively move their fronto-parietal and default networks more than their visual-motor networks. Figure S14 . Examining Effects of Long-term Antipsychotic Treatment on Cortical Gray Matter (CGm) Variance Effects. One concern regarding present cross-diagnostic results pertains to cumulative effects of antipsychotic treatment over extended periods of time, which may differ across diagnostic groups. The cumulative medication impact is very difficult to quantify accurately, particularly the precise level and exact duration of compounding medication effects on brain function in SCZ. Here we attempted a proxy analysis that adds confidence that the core clinical SCZ effects are not confounded by medication. Specifically, we identified N=25 bipolar patients who were treated in conjunction with anti-psychotic medication during their illness course (BD AP). Next, we explicitly compared the CGm (A) power and (B) variance profiles between SCZ and bipolar patients that received long-term antipsychotic treatment (BD AP) as well as those bipolar patients that were not treated by antipsychotics (BD No AP). The core SCZ effects still remained evident across both comparisons for power (SCZ vs. BD-AP [t(206)=2.16, p<.035]; SCZ vs. BD-noAP [t(183)=1.99, p<.05]) as well as variance (SCZ vs. BD-AP [t(206)=2.17, p<.032]; SCZ vs. BD-noAP [t(183)=2.05, p<.045]) measures. Moreover, the effects indicated a marginally lower level of CGm power/variance for the BD AP patients. Put simply, those BD patients who received antipsychotic treatment exhibited marginally lower, not higher variance profiles -an effect that is inconsistent with the possibility that long-term anti-psychotic treatment alone is driving the core SCZ results. Nevertheless, longitudinal studies that carefully quantify the level of medication over time can further establish the impact of long-term medication dose/type on present effects. Here we found that the original parameter choices, without a common shared signal, produced results that were somewhat unrealistic given the known large contribution of GS in empirical data (see Fig. 1 ). For instance, in our empirical data, we found that ~90% of the variance of the healthy control BOLD signal was accounted for by the GS component (although this likely collapses neuronal and physiological signal present in vivo). Therefore, we implemented a common noise input into our model architecture. Here we show a full parameter sweep of w (x-axis), G (y-axis), and magnitude of shared noise (zaxis) parameters and examine the percentage of signal variance that is attributed to the global signal (GS) component in the model. As the shared signal component increases (z-axis) we found that the percentage of signal variance attributable to the GS increased (color bar on the right; also marked as increasing circles). This was a generic property of the model irrespective of w/G parameter combinations; we selected a model regime where simulated neuronal GS accounted for 77% of the total simulated BOLD signal variance at default w/G values (cyan circle). 
